Osaka and Tokyo, Japan, February 26, 2016—Takeda Pharmaceutical Company Limited (Head office, Chuo-ku, Osaka; President and CEO, Christophe Weber; hereafter "Takeda") and Otsuka Pharmaceutical Co., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback